CureVac
Latest
Curevac, GSK’s new COVID variant vaccine effective in animal studies
FRANKFURT, April 21 (Reuters) - CureVac and GSK's second-generation mRNA vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on rodents, CureVac…
UPDATED: Germany says vaccine rollout on track despite CureVac trial flop
A failure of German biotech CureVac to meet its efficacy goal in a late-stage trial for its COVID-19 vaccine will not impact…
CureVac-GSK coronavirus variant vaccine generates good immune response in rats
A second-generation COVID-19 vaccine developed by CureVac and GlaxoSmithKline, designed to protect against coronavirus variants, produced a high level of immune response…
CureVac’s shot ready in Europe by May
The COVID-19 vaccine by German biotech firm CureVac candidate should be "ready" in Europe by the end of May, while Europe's medicines…
EU regulator begins real-time review of CureVac’s COVID-19 vaccine
Europe's drugs regulator said on Friday it had launched a real-time review of CureVac's COVID-19 vaccine to speed up potential approvals and…
CureVac strikes COVID-19 vaccine alliance with Bayer
German biotech firm CureVac has agreed an alliance with drugmaker Bayer to help it seek regulatory approval for its experimental COVID-19 vaccine…
CureVac plans global late-stage COVID-19 vaccine trial
Germany's CureVac NV said it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a decisive global…
Tesla to make molecule printers for German COVID-19 vaccine developer CureVac
Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car…
First results of CureVac COVID-19 vaccine trial expected in 2 months
The first trial results of a coronavirus vaccine being developed by CureVac are expected in two months, German news website Focus Online…
Coronavirus vaccine could be on market in mid-2021 – CureVac
A vaccine against the coronavirus pandemic by CureVac could be on the market in mid-2021, the unlisted German company said on Wednesday.…